{
    "Project Title": "SAR439774 (formerly ALN-AT3SC) (fitusiran) Clinical Study Protocol ALN-AT3SC-003",
    "Sponsor": "Sanofi Genzyme",
    "Study Number": "EFC14768",
    "Protocol Version and Date": "Version not specified, Date: 27 Jun 2018",
    "Study Title": "ALN-AT3SC-003",
    "Phase": "Phase 3",
    "Therapeutic Area": "Hemophilia A or B",
    "Number of Patients": "Approximately 54 patients",
    "Number of Sites": "Approximately 100 clinical study centers worldwide",
    "Indication": "Severe hemophilia A or B with inhibitors",
    "Duration of Treatment": "9 months",
    "Schedule of Assessments": "Table 1, Schedule of Assessments",
    "questionnaires": [
        {
            "longName": "Haemophilia Quality of Life Questionnaire for Adults",
            "shortName": "Haem-A-QOL",
            "type": "PRO",
            "questionnaireSchedule": "To be administered over the study duration based on patient age (\u226517 years)",
            "questionnaireTiming": [
                "Study Day (\u00b1Visit Window)   (Study Visit (Month)  ): -60 to -1",
                "Study Day (\u00b1Visit Window)   (Study Visit (Month)  ): Day 1  (Baseline ) (Onset Period  ) (Treatment Period  )",
                "Study Day (\u00b1Visit Window)   (Study Visit (Month)  ): 15 \u00b13",
                "Study Day (\u00b1Visit Window)   (Study Visit (Month)  ): 29 \u00b17   (Month 1 ) (Efficacy Period  )",
                "Predose",
                "Postdose 10 min (\u00b15 min)d",
                "Postdose 60 min (\u00b15 min)d"
            ]
        },
        {
            "longName": "Hemophilia Quality of Life Questionnaire for children and adolescents",
            "shortName": "Haemo-QOL",
            "type": "PRO",
            "questionnaireSchedule": "To be administered over the study duration based on patient age (<17 years)",
            "questionnaireTiming": [
                "Study Day (\u00b1Visit Window)   (Study Visit (Month)  ): Day 1  (Baseline ) (Onset Period  ) (Treatment Period  )"
            ]
        },
        {
            "longName": "Treatment Satisfaction Questionnaire for Medication",
            "shortName": "TSQM-9",
            "type": "PRO",
            "questionnaireSchedule": "Administered as specified in the Schedule of Assessments",
            "questionnaireTiming": [
                "Study Day (\u00b1Visit Window)   (Study Visit (Month)  ): Day 1  (Baseline ) (Onset Period  ) (Treatment Period  )"
            ]
        },
        {
            "longName": "Hemophilia Activities List",
            "shortName": "HAL",
            "type": "PRO",
            "questionnaireSchedule": "Administered as specified in the Schedule of Assessments (patients \u226518 years)",
            "questionnaireTiming": [
                "Study Day (\u00b1Visit Window)   (Study Visit (Month)  ): Day 1  (Baseline ) (Onset Period  ) (Treatment Period  )"
            ]
        },
        {
            "longName": "Pediatric Hemophilia Activities List",
            "shortName": "pedHAL",
            "type": "PRO",
            "questionnaireSchedule": "Administered as specified in the Schedule of Assessments (patients <18 years)",
            "questionnaireTiming": [
                "Study Day (\u00b1Visit Window)   (Study Visit (Month)  ): Day 1  (Baseline ) (Onset Period  ) (Treatment Period  )"
            ]
        },
        {
            "longName": "EuroQol-5 Dimension",
            "shortName": "EQ-5D",
            "type": "PRO",
            "questionnaireSchedule": "Administered as specified in the Schedule of Assessments",
            "questionnaireTiming": [
                "Study Day (\u00b1Visit Window)   (Study Visit (Month)  ): Day 1  (Baseline ) (Onset Period  ) (Treatment Period  )"
            ]
        },
        {
            "longName": "Hemophilia Joint Health Score",
            "shortName": "HJHS",
            "type": "ClinRO",
            "questionnaireSchedule": "Administered as specified in the Schedule of Assessments",
            "questionnaireTiming": [
                "Study Day (\u00b1Visit Window)   (Study Visit (Month)  ): Day 1  (Baseline ) (Onset Period  ) (Treatment Period  )"
            ]
        }
    ]
}